The baby’s dark brown eyes (left) turn indigo (right).
In a rare example of a medical side effect, a 6-month-old boy’s dark brown eyes turned deep blue after receiving treatment for common COVID-19.
According to medical journals Pediatric frontierA baby in Thailand was diagnosed with COVID-19 after a day of fever and cough. He had been treated with the drug favipiravir for three days, and this treatment improved his symptoms of the new coronavirus. However, just 18 hours after starting the medication, the mother observed the baby’s eye color change from dark brown to light blue.
After observing the change in color, the doctor ordered treatment to be discontinued.
“No bluish discoloration was observed in other areas such as skin, nails, oral mucosa, and nasal mucosa. Symptoms improved within 3 days of favipiravir treatment. , advised the patient to discontinue treatment.The cornea returned to its original state,”the color returned to normal five days after stopping the drug,”the authors said. medical report Said.
Note that Favipiravir, an antiviral treatment approved by Thailand’s Ministry of Public Health in 2022, is intended for children experiencing mild to moderate symptoms of COVID-19. Worth doing.
In a similar incident, occurred in 2021, a 20-year-old man from India reported the first occurrence of an unusual side effect to treatment. On the second day of treatment with favipiravir, his originally dark brown eyes turned light blue.
In the report’s conclusion, the medical experts said, “This case report highlights unusual side effects of favipiravir therapy in the youngest patient known to receive drugs to treat SARS-CoV-2 infection.” Stated. Oral antiviral treatment for children with COVID-19, but its safety profile in still-developing children is unknown. ”
